|
[1]Beuers U, Boyer JL, Paumgartner G. Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic application[J]. Hepatology, 1998, 28∶1449-1453.
|
|
[2]Paumgartner G. Ursodeoxycholic acid treatment of primary biliary cirrhosis: potential mechanisms of action[M]. In: LindorKD, Heathcote Ej, Poupon R, eds. Primary Biliary Cirrhosis: From Pathogenesis to Clinical Treatment. Dordrecht: Kluwer Academic Publishers, 1998.138-146.
|
|
[3]Tanaka M, Nakura H, Tateishi T, et al. Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury[J]. J Hepatol, 1999, 31 (2) ∶263-270.
|
|
[4]Rodrigues CM, Fan G, Ma X, et al. A novel role for ursodeoxycholic acid in inhibiting mitochondrial membrane perturbation[J]. J Clin Invest, 1998, 101∶2790-2799.
|
|
[5]Angulo P, Lindor KD. Managent of primary biliary cirrhosis and autoimmune cholangitis[J]. Clin Liver Dis, 1998, 2∶333-351.
|
|
[6]Combes B, Carithers RL Jr, Maddrey WC, et al. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid[J]. Hepatology, 1999, 29 (6) ∶1649-1654.
|
|
[7]Degott C, Zafrani ES, Callard P, et al. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression[J]. Hepatology, 1999, 29 (4) ∶1007-1012.
|
|
[8]Angulo P, Batts KP, Therneau TM, et al. Long term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis[J]. Hepatology, 1999, 29 (3) ∶644-647.
|
|
[9]Pasha T, Heathcote J, Gabriel S, et al. Cost effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis[J]. Hepatology, 1999, 29 (1) ∶21-26.
|
|
[10] Lindor KD. Ursodial for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group[J]. NEJM, 1997, 336∶691-695.
|
|
[11]Nicastri PL, Diaferia-A, Tartagni-M, et al. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy[J]. Br J Obstet Gynaecol, 1998, 105 (11) ∶1205-1207.
|
|
[12]Brites D, Rodrigues CM, Oliveira N, et al. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy[J]. J Hepatol, 1998, 28 (1) ∶91-98.
|
|
[13]Brites D, Rodrigues CM, et al. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts][J]. J Hepatol, 1998, 29 (5) ∶743-751.
|
|
[14]Serrano MA, Brites D, Larena MG, et al. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta[J]. J Hepatol, 1998, 28 (5) ∶829-839.
|
|
[15]Bahrle S, Szabo G, Stieh1 A, et al. Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejection[J]. J Heart Lung Transplant, 1998, 17 (6) ∶592-598.
|
PDF下载 ( 92 KB)
本文二维码
下载:
